发明名称 |
CHONDROITINASE ABC FOR DISK HERNIATION |
摘要 |
The present invention provides a therapeutic agent for disk herniation, which has extremely few adverse side effects, can achieve a prolonged pain-ameliorating effect when administered in only a single dose, and can exhibit a high therapeutic effect and high safety in clinical applications. The present invention relates to a therapeutic agent for disk herniation, which is characterized by containing chondroitinase ABC as an active ingredient and being administered in such a manner that the ingredient can be administered into a human disk in an amount of 1-8 units per disk. |
申请公布号 |
CA2821244(C) |
申请公布日期 |
2016.08.09 |
申请号 |
CA20112821244 |
申请日期 |
2011.12.13 |
申请人 |
SEIKAGAKU CORPORATION |
发明人 |
SIROGANE, TAIICHI;MURAYAMA, TAKAO;YAGUCHI, MASAFUMI |
分类号 |
A61K38/43;A61P19/00;A61P25/00 |
主分类号 |
A61K38/43 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|